Partnership and innovation in the pharmaceutical industry: the case of clinical research

Roberto Ippoliti, Giovanni Ramello () and Frederic M. Scherer

Economics of Innovation and New Technology, 2021, vol. 30, issue 3, 317-334

Abstract: This study attempts to test the hypothesis that collaborative research projects boost R&D performance. More specifically, through an empirical investigation, it ascertains which organizational solution best enhances scientific impact, focusing on a sample of phase II and III clinical trials and using citations in scientific journals as a measure. The main findings confirm that there are substantial differences in the ability of distinct research organizations to foster innovation, with the collaborative solution more likely to be productive. All in all, this result supports the literature asserting that collaborative networks play a productive role in knowledge domains. It may also offer an explanation for the puzzle characterizing the pharmaceutical industry, where extensive consolidation has coincided with a fall in R&D productivity.

Date: 2021
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.1080/10438599.2019.1701782 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:ecinnt:v:30:y:2021:i:3:p:317-334

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/GEIN20

DOI: 10.1080/10438599.2019.1701782

Access Statistics for this article

Economics of Innovation and New Technology is currently edited by Professor Cristiano Antonelli

More articles in Economics of Innovation and New Technology from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().